Management of Type-2 Diabetic Patients Treated With Insulin During the Ramadan
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 245 participants.
Also called NCT01354925
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 245 participants
- Sponsor
- Registry
-
NCT01354925
-
- Other papers using this trial's data
- Effect of a new insulin treatment regimen on glycaemic control and quality of life of Muslim patients with type 2 diabetes mellitus during Ramadan fast - an open label, controlled, multicentre, cluster randomised study
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Israel
- Registry status
- Completed
Technical summary
Registry record NCT01354925. Randomized; no masking; primary purpose treatment. Start 2011-09 (registry gives no type); primary completion 2011-09 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Management of Type-2 Diabetic Patients Treated With Insulin During the Ramadan
- Acronym
- DMR
- Condition
- Diabetes Type 2
- Condition
- Treatment During Ramadan
- Intervention (Drug)
- Insulin treatment during Ramadan
- Intervention (Drug)
- Standard of care
- Lead sponsor
- Meir Medical Center
Record details
- Record id
cardio:ct-nct01354925- Content hash
2593f676b161f003b2123bacbfcd9db0aca83ccc76ffa2700563f795f6ee95fd